<b>netmeta</b>: An <i>R</i> Package for Network Meta-Analysis Using Frequentist MethodsSara Balduzzi, Guido Schwarzer, Gerta Rücker et al.|Journal of Statistical Software|2023Cited by 451
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancerMaria Vittoria Dieci, Valentina Guarneri, Antonella Ferro et al.|Annals of Oncology|2019Cited by 96
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized TrialPierFranco Conte, Valentina Guarneri, Federico Piacentini et al.|Journal of Clinical Oncology|2023Cited by 25
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early <i>ERBB2</i>-Positive Breast CancerMaria Vittoria Dieci, Valentina Guarneri, Giancarlo Bisagni et al.|JAMA Oncology|2025Cited by 17
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancerMaria Vittoria Dieci, Valentina Guarneri, PierFranco Conte et al.|JNCI Journal of the National Cancer Institute|2023Cited by 14